Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

por Yang, James C. H., Brose, Marcia S., Castro, Gilberto, Kim, Edward S., Lassen, Ulrik N., Leyvraz, Serge, Pappo, Alberto, López-Ríos, Fernando, Reeves, John A., Fellous, Marc, Penault-Llorca, Frédérique, Rudzinski, Erin R., Tabatabai, Ghazaleh, Vassal, Gilles, Drilon, Alexander, Trent, Jonathan
Publicado 2022

Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an inte...

por Fong, Chin Heng, Meti, Nicholas, Kruser, Timothy, Weiss, Jessica, Liu, Zhihui Amy, Takami, Hirokazu, Narita, Yoshitaka, de Moraes, Fabio Ynoe, Dasgupta, Archya, Ong, Choo Khoon, Yang, James C. H., Lee, Jih Hsiang, Kosyak, Natalya, Pavlakis, Nicholas, Kongkham, Paul, Doherty, Mark, Leighl, Natasha B., Shultz, David B.
Publicado 2023

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

por Yang, James C.H., Kim, Sang-We, Kim, Dong-Wan, Lee, Jong-Seok, Cho, Byoung Chul, Ahn, Jin-Seok, Lee, Dae H., Kim, Tae Min, Goldman, Jonathan W., Natale, Ronald B., Brown, Andrew P., Collins, Barbara, Chmielecki, Juliann, Vishwanathan, Karthick, Mendoza-Naranjo, Ariadna, Ahn, Myung-Ju
Publicado 2020

Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial

por Mazieres, Julien, Paik, Paul K., Garassino, Marina C., Le, Xiuning, Sakai, Hiroshi, Veillon, Remi, Smit, Egbert F., Cortot, Alexis B., Raskin, Jo, Viteri, Santiago, Wu, Yi-Long, Yang, James C. H., Ahn, Myung-Ju, Ma, Rui, Zhao, Jun, O’Brate, Aurora, Berghoff, Karin, Bruns, Rolf, Otto, Gordon, Johne, Andreas, Felip, Enriqueta, Thomas, Michael
Publicado 2023

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

por Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C. H., Han, Ji-Youn, Hochmair, Maximilian J., Lee, Ki Hyeong, Delmonte, Angelo, García Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander, Gettinger, Scott N., Tiseo, Marcello, Lin, Huamao M., Gupta, Neeraj, Hanley, Michael J., Ni, Quanhong, Zhang, Pingkuan, Popat, Sanjay
Publicado 2020